Search clinical trials for: Belantamab Mafodotin
Total 72 results
-
PETHEMA FoundationGlaxoSmithKlineRecruitingRELAPSED AND/OR REFRACTORY MULTIPLE MYELOMASpain
-
University of PennsylvaniaGlaxoSmithKlineRecruiting
-
Medical College of WisconsinTerminatedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Medical University of ViennaNot yet recruitingMultiple Myeloma | Corneal Diseases | Corneal Cyst
-
M.D. Anderson Cancer CenterRecruiting
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Stichting European Myeloma NetworkGlaxoSmithKlineActive, not recruitingAL AmyloidosisNetherlands, Germany, Greece, France, Italy, United Kingdom
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Greece, Korea, Republic of, Singapore
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Jacob Soumerai, MDGlaxoSmithKlineRecruitingRelapsed Plasmablastic Lymphoma | Refractory Plasmablastic Lymphoma | Anaplastic Lymphoma Kinase Positive Large B-Cell LymphomaUnited States
-
GlaxoSmithKlineCompletedMultiple MyelomaUnited States, Spain, France, Australia, United Kingdom, Canada, Italy, Germany
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Taiwan, Poland, Thailand, Germany, France, Ireland, Greece, Korea, Republic of, United Kingdom, Australia, Italy, India, Argentina, Canada, Spain, Switzerland, Brazil, Mexico
-
GlaxoSmithKlineRecruitingMultiple MyelomaGreece, Korea, Republic of, United States
-
Fondazione EMN Italy OnlusCompleted
-
GlaxoSmithKlineCompleted
-
Janssen Research & Development, LLCWithdrawnRelapsed/ Refractory Multiple MyelomaUnited States, Poland
-
Yale UniversityGlaxoSmithKlineRecruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaKorea, Republic of, France
-
Hellenic Society of HematologyGlaxoSmithKlineActive, not recruiting
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Taiwan, United Kingdom, Korea, Republic of, Japan, Poland, Turkey, Argentina, Brazil
-
GlaxoSmithKlineAvailable
-
Universitätsklinikum Hamburg-EppendorfRecruitingMultiple Myeloma | Multiple Myeloma in RelapseGermany
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedMultiple MyelomaSpain, Germany, United States, Canada
-
M.D. Anderson Cancer CenterRecruiting
-
GlaxoSmithKlineRecruiting
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Canada, Italy, Poland, Spain, Belgium, Israel, Russian Federation, Japan, New Zealand, Korea, Republic of, Czechia, China, Netherlands, United Kingdom, United States, France, Greece, Brazil, Germany
-
Memorial Sloan Kettering Cancer CenterActive, not recruiting
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCWithdrawnMultiple Myeloma, RefractoryUnited States
-
GlaxoSmithKlineIqvia Pty LtdCompletedMultiple MyelomaUnited States, Australia, Spain, United Kingdom, Canada
-
GlaxoSmithKlineActive, not recruiting
-
GlaxoSmithKlineRecruitingMultiple Myeloma | Newly Diagnosed Multiple MyelomaKorea, Republic of, Argentina
-
Wake Forest University Health SciencesGlaxoSmithKline; AmgenRecruitingMultiple MyelomaUnited States
-
PETHEMA FoundationGlaxoSmithKlineRecruitingMultiple MyelomaSpain
-
Mayo ClinicRecruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic DiseaseGreece
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
Washington University School of MedicinePfizer; National Comprehensive Cancer Network; Rapid NovorRecruitingMultiple MyelomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
University of ChicagoGlaxoSmithKline; AmgenRecruitingMultiple Myeloma | Relapse Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineNot yet recruitingNeoplasms | Multiple Myeloma | Neoplasms, Plasma Cell | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Multiple Myeloma in Relapse | Gammopathy, Monoclonal | Haematologic Disease
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Not yet recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Hellenic Society of HematologyGlaxoSmithKlineRecruitingNeoplasms | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Corneal Disease | Gammopathy, Monoclonal | Haematologic Disease | Neoplasm, Plasma CellGreece